Quavonlimab

Product Graph
416€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Quavonlimab
category
Biosimilars
provider
Abbexa
reference
abx831677
tested applications
ELISA, WB

Description

Quavonlimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CTLA4, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Biosimilars
Immunogen Target
CTLA4
Host
Human
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG1 Kappa
Expression
Recombinant
Purity
> 95%
Purification
Purified from cell culture supernatants by Protein A/G chromatography.
Size 1
100 µg
Size 2
1 mg
Form
Liquid
Tested Applications
ELISA, WB
Buffer
0.01 M PBS. pH 7.4.
Availability
Shipped within 7-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
Biosimilars
Status
RUO
Note
Concentration: Batch-dependent, typically between 0.5-2.0 mg/ml.
CAS Number: 2254059-25-9
This product is for research use only.  Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products
AA E-1000
Androstenedione ELISA
Enzyme immunoassay for the quantitative measurement of androstenedione in serum and EDTA plasma.
Ver Producto
AA E-1000R
Androstenedione ELISA
Enzyme immunoassay for the quantitative measurement of androstenedione in serum and EDTA plasma.
Ver Producto
AA E-1100
DHEA-S ELISA
Enzyme immunoassay for the direct quantitative determination of DHEA-S in human serum.
Ver Producto